© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon, cutting its shareholding to 4.2% in the world’s largest standalone consumer healthcare firm.
GSK sold around 300 million shares in its spun-off unit at a price of 326 pence per share.
($1 = 0.7918 pounds)
This text was written byComply withI'm Gen Alpha. I've greater than 14 years of funding expertise, and an MBA in...
This text was written byObserveI take a long-term, top-down method to investing, beginning with macro and secular tendencies. I concentrate...
iA Monetary Company Inc. (OTCPK:IAFNF) Q1 2025 Earnings Convention Name Could 8, 2025 12:00 PM ET Firm Individuals Caroline Drouin...
With so many inventory selecting providers and monetary analysis platforms obtainable immediately, it may be arduous to separate the noise...
In the event you’re looking for data-driven funding insights and a approach to save when you study, Moby stands out...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
